Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy conceptAlessandro Vitale, Francesco Paolo Russo, Quirino Lai et al.|The Lancet Oncology|2023Cited by 184
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysisMaria Guarino, Andrea Casadei‐Gardini, Luca Viganò et al.|Digestive and Liver Disease|2018Cited by 61
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in ItalyValentina Burgio, Andrea Casadei‐Gardini, Massimo Iavarone et al.|Cancer Management and Research|2021Cited by 38